Bioorganic and Medicinal Chemistry Letters p. 6218 - 6223 (2012)
Update date:2022-09-26
Topics:
Du, Xiaohui
Kim, Yong-Jae
Lai, Sujen
Chen, Xi
Lizarzaburu, Mike
Turcotte, Simon
Fu, Zice
Liu, Qingxiang
Zhang, Ying
Motani, Alykhan
Oda, Kozo
Okuyama, Ryo
Nara, Futoshi
Murakoshi, Michiko
Fu, Angela
Reagan, Jeff D.
Fan, Peter
Xiong, Yumei
Shen, Wang
Li, Leping
Houze, Jonathan
Medina, Julio C.
GPR142 is a novel GPCR that is predominantly expressed in pancreatic β-cells. GPR142 agonists potentiate glucose-dependent insulin secretion, and therefore can reduce the risk of hypoglycemia. Optimization of our lead pyridinone-phenylalanine series led to a proof-of-concept compound 22, which showed in vivo efficacy in mice with dose-dependent increase in insulin secretion and a decrease in glucose levels.
View MoreContact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Sichuan WeiKeqi Biological Technology Co., Ltd.
Contact:86-028-81700200
Address:sichuan Chengdu Qingjiang Zhonglu 63号
Suzhou Time-chem Technologies Co., Ltd.
Contact:0512-63983931/68086856
Address:No. 1326 of Binhe Road, New District, Suzhou, Jiangsu, P. R. China
Beijing Cooperate Pharmaceutical Co.,Ltd
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
JIANGXI XINXIN CHEMICAL CO., LTD.
Contact:86-15957176628
Address:INDUSTRY ROAD 1, INDUSTRIAL PARK, HEKOU TOWN,YANSHAN COUNTY, JIANGXI PROVINCE, CHINA
Doi:10.1021/jo00297a034
(1990)Doi:10.1002/(SICI)1099-0690(199912)1999:12<3369::AID-EJOC3369>3.0.CO;2-P
(1999)Doi:10.1016/j.bmcl.2011.10.013
(2011)Doi:10.1039/DT9880001357
(1988)Doi:10.1021/acs.organomet.9b00770
(2020)Doi:10.1016/j.tet.2010.12.040
(2011)